Gorka Ruiz de Garibay

6PUBLICATIONS
40CO-AUTHORS
Molecular targetsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 24, 2022
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer.

Myrto K Moutafi, Magdalena Molero, Sandra Martinez Morilla

|Apr 08, 2022
Modification of BRCA1-associated breast cancer risk by HMMR overexpression.

Francesca Mateo, Zhengcheng He, Lin Mei

|Jan 21, 2022
CDK5RAP3, a New BRCA2 Partner That Regulates DNA Repair, Is Associated with Breast Cancer Survival.

Jordi Minguillón, María José Ramírez, Llorenç Rovirosa

|Aug 22, 2021
Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants.

Gorka Ruiz de Garibay, Ignacio Fernandez-Garcia, Sylvie Mazoyer

|Aug 11, 2021
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.

Carmen Herranz, Francesca Mateo, Alexandra Baiges

|Nov 11, 2020
Low-Intensity Sonoporation-Induced Intracellular Signalling of Pancreatic Cancer Cells, Fibroblasts and Endothelial Cells.

Ragnhild Haugse, Anika Langer, Elisa Thodesen Murvold

Pageof 1

Frequent Collaborators

4 joint publications

Miquel Angel Pujana

3 joint publications

Antonio Gómez

2 joint publications

Daniel Cuadras

1 joint publications

Ragnhild Haugse